Minerva Surgical, Inc.
UTRS
$0.00
$0.000.00%
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Net Income | 36.61% | -54.66% | -3.83% | -157.78% | -251.29% |
Total Depreciation and Amortization | -46.29% | -26.36% | -5.77% | 3.03% | 2.98% |
Total Amortization of Deferred Charges | 9.52% | 6.45% | 4.92% | 966.67% | -94.32% |
Total Other Non-Cash Items | -36.93% | 147.68% | -6.51% | 82.57% | 152.55% |
Change in Net Operating Assets | -113.50% | -658.67% | -9.54% | -26.79% | 76.69% |
Cash from Operations | 25.11% | -74.85% | -9.98% | -41.28% | -32.90% |
Capital Expenditure | -750.00% | 68.29% | 8.54% | -82.89% | 99.51% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -750.00% | 68.29% | 8.54% | -82.89% | 99.51% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -100.00% | -- | 892,366.67% | -100.00% | -8.11% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | 100.00% | -- |
Cash from Financing | -100.00% | 338.89% | 635.80% | -100.00% | -64.86% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 24.73% | -72.92% | 244.15% | -145.21% | -23.74% |